IHC showed that the five markers, HYAL-1, HAS-2, N-Cadh, Slug, and MMP-9 included in the CM-6 signature, were upregulated in tumor tissues from patients who developed metastasis compared to normal colon tissues and in tumors from patients who did not develop metastasis (Figure 3D). The gene discussed is HAS2; the disease is neoplasm.